Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deciphering Mechanisms Underlying Cancer Immunogenicity

NCT03958240 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT03958240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03958240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deciphering Mechanisms Underlying Cancer Immunogenicity
Lead sponsor
Institut Claudius Regaud
Phase
Not applicable
Overall status
Recruiting
Start date
January 17, 2020
Completion date
January 31, 2033
Enrollment
1,100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, cervical cancer, cervical intraepithelial neoplasia 3, glioblastoma multiforme of brain stem, head and neck cancer, non small cell lung cancer, ovarian cancer